McDonald E, Swoboda DM. Management of Myelodysplastic Syndrome in Pregnant Patients: Treatment Approaches and Considerations.
Semin Hematol 2024;
61:465-469. [PMID:
39603906 DOI:
10.1053/j.seminhematol.2024.11.001]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 07/21/2024] [Revised: 10/28/2024] [Accepted: 11/12/2024] [Indexed: 11/29/2024]
Abstract
Myelodysplastic Syndromes (MDS) and pregnancy are a rare combination and as such, there remains limited recommendations for treatment of this special population of patients. In this paper, we present 2 clinical cases to provide theoretical decision making for management of pregnancy in the setting of MDS based on expert opinion and accumulation of available data. We outline additional considerations and workup to help guide providers in successful management of this complex clinical dilemma.
Collapse